Related Experiment Video
Updated: Jun 20, 2026
07:35
Behavioral Characterization of Pentylenetetrazole-induced Seizures: Moving Beyond the Racine Scale
Published on: July 8, 2025
[Zolpidem dependence and withdrawal seizure]
Revue Medicale De Liege
|September 26, 2009
Summary
Zolpidem, a hypnotic imidazopiridine, is believed to have a lower risk of dependence than benzodiazepines. However, this case report details a patient experiencing zolpidem dependence and a withdrawal seizure, highlighting potential risks.
Area of Science:
- Pharmacology
- Neuroscience
- Clinical Medicine
Background:
- Zolpidem, an imidazopiridine derivative, is widely prescribed for insomnia due to its hypnotic effects.
- Its mechanism of action is distinct from benzodiazepines, theoretically reducing the risk of abuse and dependence.
- Despite its perceived safety profile, recent literature indicates emerging concerns regarding zolpidem's potential for misuse and adverse effects.
Purpose of the Study:
- To report a clinical case of zolpidem dependence.
- To document a severe withdrawal reaction, specifically a seizure, associated with zolpidem cessation.
- To contribute to the understanding of the risks associated with zolpidem use.
Main Methods:
- Case report detailing a patient's clinical presentation.
- Review of patient history, medication use, and adverse events.
- Clinical observation of withdrawal symptoms upon discontinuation of zolpidem.
Main Results:
- The patient developed significant dependence on zolpidem.
- Abrupt cessation of zolpidem led to a withdrawal seizure, a serious adverse event.
- This case underscores the potential for imidazopiridine-class drugs to cause dependence and severe withdrawal.
Conclusions:
- Zolpidem, despite its intended use and perceived safety, carries a risk of dependence and severe withdrawal reactions, including seizures.
- Healthcare providers should be vigilant regarding the potential for zolpidem abuse and dependence.
- Further research may be warranted to fully elucidate the long-term risks and management strategies for zolpidem-related dependence.
Related Concept Videos
01:14CNS Depressants: Barbiturates and Benzodiazepines
CNS depressants include drugs from the category of barbiturates and benzodiazepines. They are valuable medications for managing anxiety disorders and insomnia. Barbiturates, once used to induce and maintain sleep, have been replaced mainly by benzodiazepines due to barbiturate's toxicity, tolerance, and overdose risks. They interact with GABAA receptors, leading to sedation at low doses and potentially coma and death at higher doses. Phenobarbital, a long-acting barbiturate, possesses...
01:19Sedatives and Hypnotics Drugs: Benzodiazepines
Benzodiazepines have both sedative and hypnotic properties. They include compounds such as diazepam (Valium) and alprazolam (Xanax). Structurally, their cores are similar, consisting of the fusion of a benzene ring and a diazepine ring, but they share a common mechanism of action in the central nervous system (CNS).
Benzodiazepines work by enhancing the effects of the inhibitory neurotransmitter GABA. They bind to the GABAA receptor, increasing its affinity for GABA, which opens chloride...
Benzodiazepines work by enhancing the effects of the inhibitory neurotransmitter GABA. They bind to the GABAA receptor, increasing its affinity for GABA, which opens chloride...
01:17Sedatives and Hypnotics Drugs: Miscellaneous Agents
Sedatives and hypnotics encompass a wide range of substances, each with its unique mechanism of action, uses, and potential adverse effects.
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
01:20Antiepileptic Drugs: Potassium Channel Activators
Ezocgabine or retigabine, an antiepileptic drug of remarkable efficacy, has revolutionized the management of seizures. It is a potassium channel activator, explicitly targeting the family of Q subtype potassium channels. It enhances the transmembrane potassium currents, regulating neuronal excitability. This action stabilizes the resting membrane potential, a pivotal factor in mitigating the hyperexcitability that characterizes epilepsy.
Ezogabine has gained approval as an adjunctive treatment...
Ezogabine has gained approval as an adjunctive treatment...
01:20Sedatives and Hypnotics Drugs: Barbiturates
Sedatives and hypnotics encompass a drug class that acts on the central nervous system (CNS) to alleviate anxiety, promote relaxation and induce sleep.These drugs function by amplifying the actions of the neurotransmitter γ-aminobutyric acid (GABA), resulting in reduced neuronal activity. Barbiturates, a subset of sedatives and hypnotics first synthesized in the late 1800s, are categorized into ultra-short, short, intermediate, and long-acting groups based on their duration of effect. A key...
01:23Sedatives and Hypnotics: Overview
Sedatives are drugs that alleviate anxiety, while hypnotics induce sleep. Both classes of medication suppress neuronal activity, leading to a calming effect for sedatives and facilitating sleep for hypnotics.
Sedative-hypnotics are categorized into barbiturates, benzodiazepines (BZDs), and non-benzodiazepines or Z-drugs. These drugs work by suppressing central nervous system activity, and this suppression is dose-dependent. Older sedative medications, like barbiturates, follow a linear curve in...
Sedative-hypnotics are categorized into barbiturates, benzodiazepines (BZDs), and non-benzodiazepines or Z-drugs. These drugs work by suppressing central nervous system activity, and this suppression is dose-dependent. Older sedative medications, like barbiturates, follow a linear curve in...